Variant report
Variant | nsv1051015 |
---|---|
Chromosome Location | chr13:54100401-54125854 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs9536451 | chr13:54100401-54100402 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs150039559 | chr13:54100448-54100449 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs78087369 | chr13:54100487-54100488 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs145318022 | chr13:54100507-54100508 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs544791345 | chr13:54100552-54100553 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs75438761 | chr13:54100554-54100555 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs572330986 | chr13:54100592-54100593 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs541209691 | chr13:54100596-54100597 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs561284859 | chr13:54100597-54100598 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs188755715 | chr13:54100601-54100602 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs544055941 | chr13:54100603-54100604 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs563551496 | chr13:54100623-54100624 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs532512937 | chr13:54100638-54100639 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs145383328 | chr13:54100670-54100671 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs566163088 | chr13:54100731-54100732 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs146450888 | chr13:54100759-54100760 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs367746555 | chr13:54100761-54100762 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs191657971 | chr13:54100854-54100855 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs140850236 | chr13:54100864-54100865 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs554750610 | chr13:54100866-54100867 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs568218473 | chr13:54100872-54100873 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs184559456 | chr13:54100964-54100965 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs537230243 | chr13:54100972-54100973 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs78819101 | chr13:54101012-54101013 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs541829337 | chr13:54101041-54101042 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs527515125 | chr13:54101052-54101053 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs538604505 | chr13:54101103-54101104 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs148275935 | chr13:54101135-54101136 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs60464442 | chr13:54101148-54101149 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs571796663 | chr13:54101198-54101199 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs140367853 | chr13:54101216-54101217 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs554754303 | chr13:54101217-54101218 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs189794973 | chr13:54101228-54101229 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs11148276 | chr13:54101324-54101325 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs563987411 | chr13:54101343-54101344 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs182572500 | chr13:54101361-54101362 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs546171399 | chr13:54101367-54101368 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs559934528 | chr13:54101374-54101375 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs187144057 | chr13:54101416-54101417 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs150356533 | chr13:54101418-54101419 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs561082314 | chr13:54101437-54101438 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs529871023 | chr13:54101463-54101464 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs376118670 | chr13:54101485-54101486 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs545419229 | chr13:54101544-54101545 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs371189997 | chr13:54101562-54101563 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs558644119 | chr13:54101592-54101593 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs549832028 | chr13:54101607-54101608 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs572507757 | chr13:54101628-54101629 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs189576516 | chr13:54101649-54101650 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs538294469 | chr13:54101656-54101657 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 18632612 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 19242612 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 17245344 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Multiple myeloma | 19135901 | CNVD |
Autism | 18414403 | CNVD |
Neurocytoma | 17123091 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Prostate cancer | 16461572 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Multiple myeloma | 17550852 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Breast cancer | 21858162 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Gastric cancer | 17908304 | CNVD |
Breast cancer | 18852474 | CNVD |
Myelofibrosis | 22110671 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Schizophrenia | 20967226 | CNVD |
Schizophrenia | 23813976 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:54097400-54102400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr13:54097800-54100600 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr13:54100600-54101600 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr13:54101600-54102200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
5 | chr13:54102000-54102200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
6 | chr13:54102400-54103600 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
7 | chr13:54103200-54104000 | Enhancers | Brain Substantia Nigra | brain |
8 | chr13:54103400-54104000 | Enhancers | Brain Hippocampus Middle | brain |
9 | chr13:54103600-54103800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
10 | chr13:54109600-54112600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
11 | chr13:54110200-54112200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
12 | chr13:54111200-54111800 | Enhancers | Fetal Brain Female | brain |
13 | chr13:54111800-54112800 | Weak transcription | Fetal Brain Female | brain |
14 | chr13:54112800-54113200 | Enhancers | Fetal Brain Female | brain |